文章名稱引用次數

• Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression105
• Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC33
• Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)32
• The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis28
• Malignant transformation risk of oral lichen planus: A systematic review and comprehensive meta-analysis26
• Immunotherapy for head and neck cancer: Recent advances and future directions23
• Survival outcomes after treatment of cancer of the oral cavity (1985-2015)23
• The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis21
• Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database20
• Carcinogenic epithelial-mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab19